Company Name: |
Angel Pharmatech, Ltd.
|
Tel: |
17317130613 |
Email: |
3358272972@qq.com |
Products Intro: |
Product Name:STX-0119 CAS:851095-32-4 Purity:98% HPLC Package:1G;5G
|
Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:STX-0119;STX0119 CAS:851095-32-4 Purity:99.42% Package:1 mg;10 mg;100 mg;200 mg;25 mg;5 mg;50 mg
|
Company Name: |
Suzhou Zhixin Biotechnology Co., Ltd.
|
Tel: |
0512-65118909 15162312715 |
Email: |
sales@szzxbio.com |
Products Intro: |
Product Name:STX-0119 CAS:851095-32-4 Purity:98%+ Package:1g;10g;100g
|
|
| STX-0119 Basic information |
Product Name: | STX-0119 | Synonyms: | STX-0119;4-Quinolinecarboxamide, N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl- | CAS: | 851095-32-4 | MF: | C22H14N4O3 | MW: | 382.37 | EINECS: | | Product Categories: | | Mol File: | 851095-32-4.mol | ![STX-0119 Structure](CAS/20180713/GIF/851095-32-4.gif) |
| STX-0119 Chemical Properties |
density | 1.374±0.06 g/cm3(Predicted) | storage temp. | 4°C, protect from light | form | Solid | pka | 9.26±0.70(Predicted) | color | White to light yellow |
| STX-0119 Usage And Synthesis |
Uses | N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide is a small molecular inhibitor of STAT3, a cancer therapeutic agent against Glioblastoma multiforme tumor cells, and a drug target. |
| STX-0119 Preparation Products And Raw materials |
|